Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
Preferred Name | Teniposide [Chemical/Ingredient] | |
Synonyms |
|
|
ID |
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006147 |
|
code |
C22638
|
|
Display_Name |
Teniposide
|
|
imported from | ||
label |
Teniposide [Chemical/Ingredient]
|
|
MeSH_CUI |
M0021161
|
|
MeSH_Definition |
A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle.
|
|
MeSH_DUI |
D013713
|
|
MeSH_Name |
Teniposide
|
|
NUI |
N0000006147
|
|
prefixIRI |
NDF-RT:N0000006147
|
|
prefLabel |
Teniposide [Chemical/Ingredient]
|
|
RxNorm_CUI |
10362
|
|
RxNorm_Name |
Teniposide
|
|
Synonym |
Demethyl Epipodophyllotoxin Thenylidine Glucoside Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-
|
|
UMLS_CUI |
C0039512
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping
Mapping To | Ontology | Source |
---|---|---|
http://purl.bioontology.org/ontology/NDFRT/N0000006147 | NDFRT | LOOM |